Medications for community pharmacists to dose adjust or avoid to enhance prescribing safety in individuals with advanced chronic kidney disease: a scoping review and modified Delphi

Jo-Anne Wilson,Natalie Ratajczak,Katie Halliday,Marisa Battistella,Heather Naylor,Maneka Sheffield,Judith G. Marin,Jennifer Pitman,Natalie Kennie-Kaulbach,Shanna Trenaman,Louise Gillis
DOI: https://doi.org/10.1186/s12882-024-03829-y
2024-10-30
BMC Nephrology
Abstract:Community pharmacists commonly see individuals with chronic kidney disease (CKD) and are in an ideal position to mitigate harm from inappropriate prescribing. We sought to develop a relevant medication list for community pharmacists to dose adjust or avoid in individuals with an estimated glomerular filtration rate (eGFR) below 30 mL/min informed through a scoping review and modified Delphi panel of nephrology, geriatric and primary care pharmacists.
urology & nephrology
What problem does this paper attempt to address?